What to do in an oncology department to face the new COVID-19 era challenges? S. K. GarattiniA. BinG. Fasola Short Communication 29 July 2020 Article: 75
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion: the impact of toxicity on quality of life (AIRC IG-13218) Giulia MarvasoSimone Giovanni GugliandoloBarbara Alicja Jereczek-Fossa Original Paper 28 July 2020 Article: 74
Suppression of PTTG1 inhibits cell angiogenesis, migration and invasion in glioma cells Lishan CuiTong RenRengong Zhuo Original Paper 28 July 2020 Article: 73
Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target Beatriz LapaAna Cristina GonçalvesAna Bela Sarmento-Ribeiro Original Paper 28 July 2020 Article: 72
Correction to: Immunohistochemical evaluation of microsatellite instability in resected colorectal liver metastases: a preliminary experience Matteo BarabinoGaetano PiccoloEnrico Opocher Correction 26 July 2020 Article: 71
Neuroendocrine breast carcinoma: a rare but challenging entity Elena TrevisiAnna La SalviaMassimo Di Maio Review Article Open access 25 July 2020 Article: 70
Prospective evaluation of an anti-cancer drugs management programme in a dedicated oral therapy center (DICTO programme) Elise DelucheTiffany DarbasSandrine Lavau-Denes Original Paper Open access 25 July 2020 Article: 69
CREB acts as a common transcription factor for major epigenetic repressors; DNMT3B, EZH2, CUL4B and E2F6 Cheemala AshokMurugan SelvamSudhakar Baluchamy Original Paper 24 July 2020 Article: 68
The perplexity of targeting genetic alterations in hepatocellular carcinoma Michele BaroneAlfredo Di LeoAntonio Mazzocca Perspectives in Oncology Open access 22 July 2020 Article: 67
Wee1 kinase inhibitor AZD1775 potentiates CD8+ T cell-dependent antitumour activity via dendritic cell activation following a single high dose of irradiation Bin WangLin SunZhen Tao Original Paper 21 July 2020 Article: 66
Salicylidene acylhydrazides attenuate survival of SH-SY5Y neuroblastoma cells through affecting mitotic regulator Speedy/RINGO and ERK/MAPK–PI3K/AKT signaling Suleyman ArzimanOzgur TanriverdiAysegul Yildiz Original Paper 20 July 2020 Article: 65
